You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
OWC Pharmaceutical changes independent accounting firm
Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense
Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures
MA Activity The Big Story In Mature Online Video Platform Market
Martina Cheung Backs The Quality Program
OWC Pharmaceutical Research Corp. decided not to re-engage its independent auditor M&K CPAS PLLC for the year ending Dec. 31.
The company did not have any disagreements with the outgoing accounting firm.
OWC Pharmaceutical engaged Fahn Kanne & Co. Grant Thornton Israel as the independent registered public accounting firm for the fiscal year ending Dec. 31.
The changes were effective Dec. 23.